Intech Biopharm Corporation
6461StockTWO
15.75 ▲ +0.64%
12 juin 2026
6
Intech Biopharm Corporation
15.75 ▲ +0.64%
12 juin 2026
6461StockTWO

01 / À propos

Intech Biopharm Corporation engages in developing and manufacturing generic drugs to treat respiratory diseases in Taiwan and internationally. It owns iLEF (inhaled low ethanol formulation), a metered dose inhaler platform for treating asthma and COPD; and dry powder inhaler, a product comprises of blisters and capsules. The company offers its products under the SYN006, SYN010, SYN007, Synflutide, Duasma, Synvent, and SYN011 names. Intech Biopharm Corporation was founded in 2010 and is headquartered in Taipei, Taiwan.

Arberion
Loading market data